DrugCendR's Unattributed Round

DrugCendR raised a round of funding on February 22, 2018.

DrugCendR is a biopharmaceutical company dedicated to developing next generation cancer therapies that are designed to overcome the barriers of drug delivery to solid tumors. The company's drug delive…

Articles about DrugCendR's Unattributed Round: